Skip to main content

Research Repository

Advanced Search

Phosphomimetic Mutation of the N-Terminal Lid of MDM2 Enhances the Polyubiquitination of p53 through Stimulation of E2-Ubiquitin Thioester Hydrolysis

Fraser, Jennifer A.; Worrall, Erin G.; Lin, Yao; Landre, Vivien; Pettersson, Susanne; Blackburn, Elizabeth; Walkinshaw, Malcolm; Muller, Petr; Vojtesek, Borek; Ball, Kathryn; Hupp, Ted R.

Authors

Jennifer A. Fraser

Erin G. Worrall

Yao Lin

Vivien Landre

Susanne Pettersson

Elizabeth Blackburn

Malcolm Walkinshaw

Petr Muller

Borek Vojtesek

Kathryn Ball

Ted R. Hupp



Abstract

Mouse double minute 2 (MDM2) has a phosphorylation site within a lid motif at Ser17 whose phosphomimetic
mutation to Asp17 stimulates MDM2-mediated polyubiquitination of p53. MDM2 lid deletion, but not Asp17
mutation, induced a blue shift in the λmax of intrinsic fluorescence derived from residues in the central domain
including Trp235, Trp303, Trp323, and Trp329. This indicates that the Asp17 mutation does not alter the
conformation of MDM2 surrounding the tryptophan residues. In addition, Phe235 mutation enhanced MDM2
binding to p53 but did not stimulate its ubiquitination function, thus uncoupling increases in p53 binding from its E3
ubiquitin ligase function. However, the Asp17mutation inMDM2 stimulated its discharge of the UBCH5a-ubiquitin
thioester adduct (UBCH5a is a ubiquitin-conjugating enzyme E2D 1 UBC4/5 homolog yeast). This stimulation of
ubiquitin discharge fromE2 was independent of the p53 substrate. There are now four known effects of the Asp17
mutation on MDM2: (i) it alters the conformation of the isolated N-terminus as defined by NMR; (ii) it induces
increased thermostability of the isolated N-terminal domain; (iii) it stimulates the allosteric interaction ofMDM2 with
the DNA-binding domain of p53; and (iv) it stimulates a novel protein–protein interaction with the E2-ubiquitin
complex in the absence of substrate p53 that, in turn, increases hydrolysis of theE2-ubiquitin thioester bond. These
data also suggest a new strategy to disrupt MDM2 function by targeting the E2-ubiquitin discharge reaction.

Journal Article Type Article
Acceptance Date Dec 19, 2014
Online Publication Date Dec 24, 2014
Publication Date Apr 24, 2015
Deposit Date May 20, 2016
Journal Journal of Molecular Biology
Print ISSN 0022-2836
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 427
Issue 8
Pages 1728-1747
DOI https://doi.org/10.1016/j.jmb.2014.12.011
Keywords Phosphomimetic mutation; E2-ubiquitin discharge;
Public URL http://researchrepository.napier.ac.uk/id/eprint/10271
Publisher URL http://dx.doi.org/10.1016/j.jmb.2014.12.011
Contract Date May 20, 2016




Downloadable Citations